| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/KI.2011.132 |
| P698 | PubMed publication ID | 21760601 |
| P2093 | author name string | Matthew R Weir | |
| P2860 | cites work | Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 |
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | Q28188182 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. | Q41680267 | ||
| Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. | Q43576144 | ||
| Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial | Q43626458 | ||
| Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? | Q50657801 | ||
| A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function | Q73150080 | ||
| An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function | Q83751680 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 235-237 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Acute fall in glomerular filtration rate with renin-angiotensin system inhibition: a biomeasure of therapeutic success? | |
| P478 | volume | 80 |
| Q34251854 | African Americans, hypertension and the renin angiotensin system |
| Q87393463 | Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients |
| Q87393483 | Chapter 6: Blood pressure management in children with CKD ND |
| Q87393485 | Chapter 8: Future directions and controversies |
| Q34156850 | Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis |
| Q90473703 | Population Pharmacokinetic and Exposure-Response Analysis of Finerenone: Insights Based on Phase IIb Data and Simulations to Support Dose Selection for Pivotal Trials in Type 2 Diabetes with Chronic Kidney Disease |
| Q93609101 | References |
| Q37263019 | What should be the blood pressure target for patients with chronic kidney disease? |
Search more.